1. Home
  2. AHCO vs NEO Comparison

AHCO vs NEO Comparison

Compare AHCO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$10.10

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$12.27

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHCO
NEO
Founded
2012
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
AHCO
NEO
Price
$10.10
$12.27
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$13.60
$11.38
AVG Volume (30 Days)
852.0K
2.0M
Earning Date
02-24-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$3,255,213,000.00
$709,162,000.00
Revenue This Year
$1.07
$10.86
Revenue Next Year
$6.49
$9.70
P/E Ratio
$18.35
N/A
Revenue Growth
N/A
10.10
52 Week Low
$7.11
$4.72
52 Week High
$11.63
$15.26

Technical Indicators

Market Signals
Indicator
AHCO
NEO
Relative Strength Index (RSI) 48.69 48.08
Support Level $9.46 $11.81
Resistance Level $10.87 $12.60
Average True Range (ATR) 0.36 0.53
MACD -0.07 -0.12
Stochastic Oscillator 43.49 31.08

Price Performance

Historical Comparison
AHCO
NEO

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: